Bluefin Capital Management’s Anterix ATEX Stock Holding History

Bluefin Capital Management’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-27,000	Closed	-$28K	–	598
2022 Q1	$28K	Buy	+27,000	New	+$1.48M	﹤0.01%	502

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCC

Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return

JCP

Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bluefin Capital Management's ATEX Position: Q2 2022 in Review

Bluefin Capital Management sold out of Anterix (ATEX) in Q2 2022, closing a stake of 19,783 shares — an estimated $1.15M sold.

Bluefin Capital Management first reported a position in ATEX in Q1 2022 and held it in 1 quarter. The position peaked at $1.15M in Q1 2022. 94 funds tracked by Wall St. Rank hold ATEX as of Q2 2022.

Bluefin Capital Management reported no remaining Anterix position as of Q2 2022 after selling out during the quarter.
Bluefin Capital Management sold 19,783 Anterix shares in Q2 2022, an estimated $1.15M.
Bluefin Capital Management first reported a position in Anterix in Q1 2022 and held it in 1 quarter.
Bluefin Capital Management's Anterix position peaked at $1.15M in Q1 2022.
94 funds tracked by Wall St. Rank held Anterix as of Q2 2022.

Based on Bluefin Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.